INTRODUCTION
Pluripotent stem cells, including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), are promising sources for regenerative medicine because of their ability to differentiate into all cell types represented in the three primary germ layers. In particular, iPSCs, which can be derived from patient tissue, have great potential to be used in patient-specific cell therapy. However, the practical application of such cells remains a distant goal because of our limited understanding of the molecular mechanisms underlying pluripotency (Hanna et al., 2010; Ng and Surani, 2011; Okita and Yamanaka, 2010; Patel and Yang, 2010) .
O-GlcNAcylation is an O-b-glycosidic attachment of single N-acetylglucosamine (GlcNAc) to serine and threonine residues of nucleocytoplasmic proteins. Similar to phosphorylation, this posttranslational modification rapidly cycles on and off hundreds of protein substrates in response to diverse biological cues. However, unlike phosphorylation, only two enzymes catalyze the addition and removal of O-GlcNAc in mammals: O-GlcNAc transferase (OGT) adds the modification and O-GlcNAcase (OGA) removes it Hu et al., 2010; Love et al., 2010; Zeidan and Hart, 2010) . Several studies have shown that O-GlcNAcylation controls diverse aspects of cellular physiology, such as nutrient and growth factor sensing, cell cycle progression, and stress response, by regulating protein function, localization, and stability Hart and Copeland, 2010; Hart et al., 2007; Love et al., 2010) . In particular, O-GlcNAcylation adjusts protein function according to the nutritional status of the cell (Zeidan and Hart, 2010) .
Glucose/nutrient conditions in culture affect ESC maintenance and differentiation, but the underlying mechanisms are poorly understood. In vitro development of early human and mouse embryos is enhanced in glucose-deficient media (Conaghan et al., 1993; Quinn, 1995) whereas addition of glucosamine during in vitro maturation inhibits embryo development (SuttonMcDowall et al., 2006) . In addition, glucose levels during formation of embryoid bodies (EBs) influence their differentiation propensity, with high glucose generating beating cardiac muscle more efficiently and low glucose promoting neuronal lineages (Mochizuki et al., 2011) . Complete loss of Ogt function is lethal to mouse ESCs (Shafi et al., 2000) . EBs with elevated O-GlcNAc levels, through treatment with glucosamine or OGA inhibitors, have impaired differentiation into cardiac cells (Kim et al., 2009) . Together these studies suggest that O-GlcNAcylation promotes ESC maintenance, and decreases in O-GlcNAcylation may be required for ESC differentiation.
The transcription factors Oct4, Sox2, Klf4 (collectively termed OSK), and Nanog are part of a core pluripotency network that controls ESC self-renewal and pluripotency and are also core factors used in reprogramming somatic cells to iPSCs (Ng and Surani, 2011; Stadtfeld and Hochedlinger, 2010) . Previous studies have shown that Sox2 undergoes O-GlcNAcylation in rat forebrain (Khidekel et al., 2004) , and Oct4 interacts with Ogt (Pardo et al., 2010; van den Berg et al., 2010) and may undergo O-GlcNAcylation (Webster et al., 2009) in ESCs. These data suggest that O-GlcNAc could directly affect core components of the pluripotency network to functionally regulate pluripotency and somatic cell reprogramming.
In the present study, we analyzed the role of O-GlcNAc in ESC maintenance and differentiation and in somatic cell reprogramming. We found that blocking O-GlcNAcylation inhibited ESC self-renewal and the efficiency of iPSC generation, whereas increasing O-GlcNAcylation during EB formation inhibited normal ESC differentiation. Moreover, we determined that Oct4 and Sox2 are modified by O-GlcNAc in mouse ESCs and that O-GlcNAc regulates their transcriptional activity. Our study reveals that O-GlcNAc controls pluripotency by directly regulating transcriptional activities of core components of the pluripotency network. These findings will expand our understanding of the reprogramming process and pluripotency at a molecular level.
RESULTS

O-GlcNAc Regulates ESC Self-Renewal and Differentiation and Somatic Cell Reprogramming
To investigate the role of O-GlcNAc in ESC maintenance, we perturbed O-GlcNAcylation by using either short hairpin RNAs (shRNAs) against Ogt (shOgt) or chemical inhibition of Oga. We selected shOgts (Figures S1A-S1C available online) that achieve incomplete knockdown and are doxycline inducible ( Figure 1A ) because complete elimination of Ogt expression is lethal to ESCs (Shafi et al., 2000) . Dox-treated E14 tTS Tet-shOgt cells (Tet-shOgt) exhibited reduced numbers of colonies compared to control shRNA-expressing cells (Tet-shMock) in colony forming assays with the majority of colonies staining negative for alkaline phosphatase (AP), suggesting that Ogt affects both ESC proliferation (via cell cycle regulation or apoptosis) and self-renewal ( Figures 1B, 1C , and S1D). O-GlcNAc levels can also be manipulated with chemicals. E14 ESCs that were treated with either streptozocin (streptozotocin; STZ), which is known to inhibit OGA via the production of a transition state analog (Toleman et al., 2006) , or glucosamine exhibited elevated global levels of O-GlcNAc ( Figure S1E ). During EB formation, the normal increase in lineage-specific marker expression and concordant decrease in pluripotency marker expression was hampered by STZ and glucosamine treatment ( Figures 1D and S1F ). These results suggest that O-GlcNAc also affects ESC differentiation.
We also investigated the role of O-GlcNAcylation in reprogramming fibroblasts to iPSCs. Transduction of Oct4-promoterdriven GFP MEFs (pOct4-GFP MEFs) with OSK transgenes induced colonies with ESC colony-like morphology. Some of them expressed GFP, a marker of endogenous Oct4 expression in our system ( Figure S1G ). All GFP-positive colonies were also positive for AP staining (Figures S1H and S1I) . In GFP-positive colonies, the expression of ESC-specific genes (Oct4, Sox2, and Nanog) was comparable to that of mouse ESCs and the transgene was nearly silenced (Figures S1J and S1K ).
In MEFs, treatment of shOgts reduced global O-GlcNAc levels ( Figure 1E ). Addition of shOgts during OSK-driven iPSC generation reduced reprogramming efficiency ( Figure 1F ), whereas overexpression of human OGT in MEFs elevated global O-GlcNAc levels ( Figure 1G ) and increased reprogramming efficiency ( Figure 1H ). Low-glucose culture medium reduces cellular O-GlcNAc levels compared to high-glucose medium ( Figure 1I ), and MEFs reprogrammed under low-glucose medium developed fewer iPSC colonies ( Figure 1J ). Collectively, these results demonstrate that O-GlcNAcylation is important for somatic cell reprogramming.
Core Components of the Pluripotency Network Are Modified by O-GlcNAc in Undifferentiated ESCs
To investigate the molecular mechanism linking O-GlcNAcylation and pluripotency, we postulated that O-GlcNAcylation directly controls core components of the pluripotency network. To test this hypothesis, we initially determined whether OSK and Nanog were modified by O-GlcNAcylation. O-GlcNAcylated proteins have high affinity for succinylated wheat germ agglutinin (sWGA) and are easily eluted by competition with GlcNAc. Therefore, we pulled-down overexpressed Myc-tagged OSK and Nanog with sWGA beads and eluted the bound proteins by competition with GlcNAc in HEK293 cells. Western blot analyses showed that OSK but not Nanog was clearly pulled down by sWGA ( Figure S2A ). We also purified sWGA-bound proteins from ESC lysates and probed for OSK and Nanog by western blot. All endogenous OSK but not Nanog bound specifically to sWGA in ESCs, and competition with GlcNAc completely eliminated their binding to sWGA (Figure 2A ).
Because sWGA binds terminal GlcNAc residues, we determined whether the OSK binding to sWGA was mediated by O-GlcNAc. Removal of terminal O-linked glycosidic modifications by b-N-Acetyl-hexosaminidase (b-hex) (Gandy et al., 2006) during sWGA pull-down reduced Oct4 and Sox2 binding to sWGA ( Figure 2B ). However, removal of N-linked GlcNAc via excess PNGase F (Gandy et al., 2006) did not affect Oct4 and Sox2 binding to sWGA ( Figure 2C ). Thus sWGA-Oct4 and -Sox2 interactions are due primarily to O-GlcNAc on Oct4 and Sox2.
We reconfirmed the O-GlcNAcylation of Oct4 and Sox2 by western blot with anti-O-GlcNAc (clone CTD110.6), which recognizes O-GlcNAcylated serine and threonine residues ( Figure 2D ). Endogenous Oct4 and Sox2 interacted with Ogt ( Figure 2E) , and a portion of nuclear Ogt colocalized with Oct4 and Sox2 ( Figures  S2B and S2C ) in undifferentiated ESCs.
During ESC differentiation into EBs, O-GlcNAcylation levels of Oct4 and Sox2 decreased rapidly. Oct4 O-GlcNAcylation levels decreased rapidly by day one and were nearly undetectable by day two, but total Oct4 protein levels remained unchanged over the same period ( Figures 2F-2H ). As controls, Ogt and Gapdh O-GlcNAcylation levels were not altered.
Mapping O-GlcNAcylation Sites on Oct4 and Sox2
To identify the O-GlcNAcylation site(s) in Oct4, we initially selected four putative O-GlcNAcylation sites by using the YinOYang prediction server. Surprisingly, replacement of all four putative serine and threonine residues with alanine did not weaken the interaction with sWGA in HEK293 cells ( Figure S3A) . 
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Next, we examined the interaction between several truncated mutants of Oct4 and sWGA. Oct4-truncated mutants, lacking transactivation domain 1 (TAD1) and TAD2, still bound to sWGA, but Oct4 deletion mutants that lacked the POU homeodomain (POU-h) failed to bind to sWGA ( Figures 3A and S3B ).
The O-GlcNAcylation of the POU domain of Oct4 was reconfirmed by western blot with anti-O-GlcNAc ( Figure 3B ) in HEK293 cells. Therefore, we chose to mutate additional putative O-GlcNAcylation sites within the POU-h. Threonine 228 (T228) and serine 229 (S229) were chosen because S229 has been identified as a phosphorylation site in the ESC phosphoproteome (Swaney et al., 2009 ) and because O-GlcNAcylation often competes with phosphorylation at the same or adjacent residues. Replacement of putative serine and threonine residues with alanine (T228A and S229A) reduced the Oct4 O-GlcNAc level ( Figure S3C ). To determine whether these mutations also reduce Oct4 O-GlcNAcylation in undifferentiated ESCs, we stably expressed wild-type (WT) and point mutants of Flagtagged Oct4 into E14 cells. Although the undifferentiated state of ESCs is sensitive to Oct4 levels (Niwa et al., 2000) , slight overexpression of Oct4 in our experiments maintained ESCs in an undifferentiated state ( Figures S3D and S3E ). Through western blot analyses, we determined that both T228A and S229A reduced Oct4 O-GlcNAc levels in ESCs ( Figure 3C ). To directly detect O-GlcNAc on Oct4 in ESC, we purified O-GlcNAcylated Oct4 from ZHBTc4 F-Oct4 cells, which express Flag-tagged Oct4 instead of endogenous Oct4 (van den Berg et al., 2010) , by serial pull-down with anti-Flag and sWGA. Purified protein was analyzed by nano-LC-ESI-MS/MS. O-GlcNAc on T228 was detected from three independent experiments in succession ( Figure 3D ). Of note, Oct4 T228 residues are highly conserved between species and among POU family members ( Figures S3F and S3G ).
The O-GlcNAcylation sequence in Sox2 has been previously determined in rat brain (Khidekel et al., 2004) , although the exact sites have not been identified ( Figure S3H ). We mutated all nine serine and threonine sites in this sequence to alanine. By using the sWGA binding assay and western blots with anti-O-GlcNAc (CTD110.6), we identified S248, T258, and S259 as O-GlcNAcylation sites (Figures S3I and S3J) . To determine whether these three sites are responsible for O-GlcNAcylation in undifferentiated ESCs, we stably expressed Flag-tagged Sox2 WT and mutant (S248A, T258A, and S259A) into E14 cells. Slight overexpression of Sox2 in our experiments maintained ESCs in an undifferentiated state ( Figure S3K ). The triple mutant exhibited reduced binding to sWGA in ESCs ( Figure S3L ). Recently, both S248 and T258 were also identified as O-GlcNAcylated residues in Sox2 by ETD MS/MS in ESCs (Myers et al., 2011) , which is consistent with our results.
An O-GlcNAcylation-Defective Mutant of Oct4 Reduces Reprogramming Efficiency and ESC Self-Renewal Having determined the O-GlcNAcylation sites in Oct4 and Sox2, we next determined the effects of O-GlcNAc on Oct4 and Sox2 function. During OSK-driven reprogramming of pOct4-GFP MEFs, we replaced wild-type Oct4 and Sox2 with their O-GlcNAcylation-defective point mutants. Substitution of Oct4 WT with T228A inhibited the development of GFP-positive colonies, with less than 5% GFP-positive colonies compared to Oct4 WT ( Figures 4A and S4A ). We also examined the effect of S229 phosphorylation on reprogramming, because S229 has been previously identified as a phosphorylation site (Swaney et al., 2009) . Substitution of Oct4 WT with S229D (replacement of serine 229 to aspartate), which mimics phosphorylation, completely blocked the induction of GFP-positive colonies ( Figures 4A and S4A ). Oct4 S229A, which cannot undergo phosphorylation, had a milder effect inducing $30% GFPpositive colonies compared to Oct4 WT. These differences in reprogramming efficiency were not caused by disparities in viral titer ( Figures S4B-S4E ). These results demonstrate that O-GlcNAcylation of Oct4 at T228 leads to an increase in Oct4 activity, whereas phosphorylation at S229 inhibits its function.
Substitution of Sox2 WT with the triple mutant (S248A, T258A, and S259A) did not alter reprogramming efficiency. However, expression of the Sox2 double mutant (T258A and S259A) induced about half as many GFP-positive colonies compared with Sox2 WT ( Figures S4F and S4G ). There were no disparities in viral titer of Sox2 WT and mutants ( Figures S4H-S4J ). These seemingly confusing results could be due to crosstalk between phosphorylation and O-GlcNAcylation. Because Sox2 S248 Sox2 function. Because the Sox2 double mutant (T258A and S259A) represses Sox2 activity, all three mutations may cancel out their effects on Sox2 function. Since we determined that Oct4 O-GlcNAcylation at T228 reduces Oct4 activity during reprogramming, we next investigated whether it affects ESC maintenance. We replaced endogenous Oct4 with O-GlcNAc-defective Oct4 using ZHBTc4 cells (Niwa et al., 2000) , which completely lose Oct4 protein within 24 hr after Dox addition . ZHBTc4 cells were infected with Flag-Oct4 WT or mutants of equivalent viral titer and Dox was added 24 hr after infection. 8 days after Dox treatment, approximately 100 colonies with undifferentiated ESC morphology appeared in Flag-Oct4 WT-infected plates whereas no colonies appeared in Flag-Mock-infected plates and only a few colonies appeared in Flag-Oct4 T228A-infected plates ( Figures 4B and 4C) , suggesting that Oct4 T228A is reduced in its capacity to maintain ESCs compared to Oct4 WT.
Although rare, Flag-Oct4 T228A was capable of forming undifferentiated colonies in infected ESCs. We attempted to examine the undifferentiated colonies from Oct4 T228A cells but failed because retroviral promoters are commonly silenced during long-term ESC culture (Pannell and Ellis, 2001 ). Therefore, we stably expressed Flag-Oct4 WT and T228A under the control of the constitutive CAG expression unit (Niwa et al., 1991 (Niwa et al., , 2002 in Dox-treated ZHBTc4 cells. Western blot analyses showed that both Flag-Oct4 WT and T228 were expressed at comparable levels and pluripotency markers (Nanog and Sox2) were also expressed similarly ( Figure S4K ). However Flag-Oct4 T228 cells were prone to differentiate during culture. Colony-forming assays showed that $50% of Flag-Oct4 T228 colonies were differentiated ( Figures 4D and S4L ), thus showing that O-GlcNAc-defective Oct4 cannot promote self-renewal efficiently.
O-GlcNAcylation Regulates Oct4 Transcriptional Activity Next, we investigated the mechanism by which O-GlcNAcylation of Oct4 influences reprogramming and ESC self-renewal. Oct4 T228A showed no apparent difference in protein stability compared to WT ( Figure S5A ). In addition, various Oct4 and Sox2 mutants used in the reprogramming assay exhibited no difference in cellular localization ( Figures S5B-S5D) .
To determine the effect of O-GlcNAcylation on Oct4 transcriptional activity, we used 103 Oct4 RE-luc, which contains ten copies of the Oct4 response element (Oct4 RE) upstream of the TATA box (Lee et al., 2005) . To rule out the activity of endogenous Oct4, NIH 3T3 cells, which do not express Oct4 (Figures 5A), were stably incorporated with 103 Oct4 RE-luc. These NIH 3T3 stable cells were infected with retroviral Oct4 WT and mutants and luciferase activity was measured 4 days after infection. In this reporter assay, Oct4 T228A (TA) and S229D (SD) barely activated luciferase expression, and S229A (SA) had $60% of WT activity ( Figure 5A ). Reporter activity of Oct4 mutants closely resembled their abilities to promote somatic cell reprogramming ( Figures 4A and 5A ).
Oct4 and Sox2 cooperate in regulating many of their targets. Therefore, we investigated the effect of O-GlcNAcylation on Oct4 activity at promoters that are synergistically regulated by Oct4 and Sox2. The reporter plasmid 63 O/S RE-luc, which contains six copies of the Oct4 and Sox2 response elements (O/S RE) upstream of the minimal Fgf4 promoter (Ambrosetti et al., 2000) , was used for this purpose. NIH 3T3 cells, which have no endogenous Oct4 and Sox2 expression, were stably incorporated with 63 O/S RE-luc. Expression of Oct4 or Sox2 alone slightly increased reporter activity, and simultaneous expression of both synergistically increased reporter activity. Oct4 TA and SD did not synergize with Sox2 to activate the reporter gene ( Figure S5E ).
Next, we investigated the dependence of Oct4 activity on O-GlcNAcylation by perturbing O-GlcNAcylation in our reporter assay. Overexpression of human OGT in NIH 3T3 cells elevated overall O-GlcNAc levels ( Figure 5B ). OGT overexpression increased reporter activity in Oct4 WT-expressing cells but not in Oct4 TA-expressing cells ( Figure 5C ). Elevating O-GlcNAcylation with STZ also increased Oct4 WT-dependent reporter activity ( Figure S5F ). Inhibition of O-GlcNAcylation with shOgt ( Figure 5D ) reduced the Oct4-dependent, but not constitutive MSCV promoter-dependent, reporter activity ( Figures 5E and S5G ). Simultaneous infection of retroviral human OGT with shOgts restored O-GlcNAc level and reporter activity demonstrating that the changes in reporter activity were not an off-target effect of shRNAs ( Figures 5D and 5E ). These results suggest that O-GlcNAcylation of Oct4 enhances its Figure 5 . O-GlcNAcylation Regulates Oct4 Transcriptional Activity (A) Ten copies of Oct4-responsive element-driven luciferase (103 Oct4 RE-luc) reporter gene was stably incorporated into the genome of NIH 3T3 cells. These stable cells, which have no endogenous Oct4, were infected with indicated retroviral Oct4 wild-type (WT) and mutants. Luciferase activity was measured 4 days after infection with a luminometer. The values are expressed as relative percent mean luminescent units ± standard deviation (n R 3). TA and SA, T228A and S229A; TA, T228A; SA, S229A; SD, S229D. (B and C) Increasing O-GlcNAc by OGT overexpression elevates Oct4 WT, but not Oct4-TA, driven reporter activity. NIH 3T3 cells stably incorporated with 103 Oct4 RE-luc reporter gene were infected with retroviral Oct4 WT or TA. Then, overall O-GlcNAc level was increased by additional infection of retroviral Flagtagged OGT. Luciferase activity was measured 4 days after infecting OGT. p values shown. (D and E) Decreasing O-GlcNAc by shOgts reduces Oct4-driven reporter activity. NIH 3T3 103 Oct4 RE-luc stable cells were infected with retroviral Oct4 WT. Then, overall O-GlcNAc level was decreased by additional infection of retroviral shRNAs against Ogt. Luciferase activity was measured 4 days after infecting shOgts. To check specific effect of shOgts, Flag-tagged human OGT was simultaneously infected with shOgts. (F) E14 cells stably incorporated with 103 Oct4 RE-luc reporter gene were differentiated into EBs with/without STZ (3 mM). Luciferase activity was measured at the indicated time points. At the same time, total Oct4 protein levels and O-GlcNAcylated Oct4 levels were determined by western blot and sWGA pull-down assay. (G) E14 cells stably incorporated with 103 Oct4 RE-luc reporter gene were cultured in different glucose concentration. Luciferase activity was measured $1 week after culture. At the same time, total Oct4 protein levels and O-GlcNAcylated Oct4 levels were determined by western blot and sWGA pull-down assay. See also Figure S5 . (A) mRNA expression levels in E14 cells before differentiation (EB 0), 2 days after differentiation to EB (EB 2), and 2 days after differentiation to EB in the presence of STZ (EB 2+ STZ) were analyzed by microarray. In addition, mRNA expression levels in ZHBTc4 cells treated with Dox for 24 hr in the presence (+D,STZ) or absence (+D) of STZ were also analyzed by microarray. The probes (genes) were grouped according to the categories indicated and the number of probes (genes) corresponding to the categories were represented with Venn diagrams. The genes in the selected category were compared with tentative Oct4 target genes from published data (Sharov et al., 2008) .
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transcriptional activity and that T228 is a major O-GlcNAcylation site that controls Oct4 transcriptional activity.
Next, we wanted to see whether O-GlcNAcylation regulates endogenous Oct4 transcriptional activity in ESCs. We stably incorporated 103 Oct4 RE-luc reporter gene into the genome of E14 cells or ZHBTc4 cells. During differentiation to EBs, reporter activities of E14 103 Oct4 RE-luc stable cells sharply decreased to less than 10% after 2 days of differentiation (Figure 5F ). At that time point, total Oct4 protein levels remained high but were almost depleted in O-GlcNAc ( Figure 5F ). STZ partially recovered both the O-GlcNAc levels and reporter activity ( Figure 5F ). Luciferase activity in ZHBTc4 103 Oct4 RE-luc stable cells was similarly decreased during differentiation and restored by STZ (Figures S5H-S5J) . However, STZ did not increase reporter activity in the presence of Dox (Figure S5K ), suggesting that STZ induced reporter activity via O-GlcNAcOct4. Reporter activities of E14 63 O/S RE-luc stable cells also displayed a similar pattern ( Figure S5L ). E14 103 Oct4 RE-luc stable cells cultured in low-glucose (5.5 mM) media had reduced O-GlcNAc-Oct4 level and reporter activity compared to cells cultured in high-glucose (25 mM) media, despite comparable levels of total Oct4 protein ( Figure 5G ). These results demonstrate that the Oct4 activity is dependent on the O-GlcNAcylation level of Oct4.
Identification of Genes Regulated by Oct4
O-GlcNAcylation We next identified Oct4 target genes upregulated by O-GlcNAcylation of Oct4. Because O-GlcNAc levels of Oct4 are significantly reduced after 2 days of differentiation to EBs without an accompanying change in Oct4 protein levels ( Figure 5F ), we postulated that expression of O-GlcNAcylated Oct4 target genes should be changed by this time point. In addition, because STZ sustained O-GlcNAc levels on Oct4 during EB formation (Figure 5F ), we postulated that the reduced expression of target genes should be recovered by STZ. However, STZ-upregulated genes may also include genes regulated by O-GlcNAcylation of proteins other than Oct4. To rule out those genes, we used ZHBTc4 cells, which lose Oct4 upon Dox treatment. Genes whose expression levels were recovered from STZ addition in Dox-treated ZHBTc4 cells may not be regulated by Oct4 O-GlcNAcylation, and so these genes were eliminated from our subsequent analyses.
In mRNA microarray experiments (Table S1 ; raw data), 203 probes (174 genes; Table S2 ) among 12,222 validated probes satisfied our criteria for potential O-GlcNAcylated Oct4 target genes ( Figure 6A, left) . These 174 genes could represent both direct and indirect targets of O-GlcNAcylated Oct4. To identify the direct targets of O-GlcNAcylated Oct4, we chose a subset of known Oct4 target genes among the list of validated probes. Among 485 tentative Oct4 target genes (622 probes) from published data (Sharov et al., 2008) , 45 genes (57 probes) were included in our set of potential O-GlcNAcylated Oct4 target genes ( Figure 6A, right) . We classified these 45 genes as potential genes directly upregulated by O-GlcNAcylated Oct4 ( Figure 6B and Table S3 ). Using a similar logic, we found three potential genes directly downregulated by O-GlcNAcylated Oct4 (Table S4) .
We confirmed a subset of our microarray data by using realtime qPCR. O-GlcNAcylated Oct4 targets selected from our data set (Nanog, Klf4, Klf2, Esrrb, and Zfp42) were indeed reduced in expression during ESC differentiation into EBs, and their expression was also recovered upon addition of STZ. In contrast, expression of Utf1, which was not identified as a potential O-GlcNAcylated Oct4 target gene, was not reduced in day 2 EBs nor significantly affected by STZ treatment ( Figure 6C ). In ZHBTc4 cells, addition of Dox nearly eliminated Oct4 protein, and STZ did not affect expression of the putative targets ( Figure S6A) .
If the selected genes are direct targets of O-GlcNAcylated Oct4, their promoters should be occupied by O-GlcNAcylated Oct4. Using serial chromatin immunoprecipitation (ChIP) and sequencing, we tested whether O-GlcNAcylated Oct4 occupied these potential target gene promoters. ZHBTc4 F-Oct4 cells were ChIPed with Flag antibody. After eluting the bound chromatin by competition with Flag peptide, eluates were re-ChIPed by sWGA agarose. Bound chromatin was eluted by competition with GlcNAc and sequenced with genome Analyzer II. 485 tentative Oct4 target genes (Sharov et al., 2008) were analyzed ( Figure 6D and Table S5 ). Among 485 genes, 271 genes showed ChIP-sequencing (ChIP-seq) signals in their gene region (defined as À10 kb from transcription stat site to +10 kb from transcription ending site). Among 45 potential O-GlcNAcylated Oct4 target genes, 29 genes, including Klf2, Klf5, Nr5a2, Tbx3, Tcl1, and Zfp42, showed ChIP-Seq signals in their gene region ( Figure 6E ). A subset of these ChIP-Seq results was confirmed by PCR ( Figure S6B ). We present these 29 genes as refined tentative O-GlcNAcylated Oct4 target genes. Key regulators of ESCs, such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1, are included in the list ( Figure 6F ).
DISCUSSION
In this study, we demonstrate that O-GlcNAc is an important regulator of pluripotency. O-GlcNAc is critical for ESC selfrenewal and somatic cell reprogramming to pluripotency. Mild knockdown of Ogt reduces ESC potential to self-renew ( Figures  1A-1C Figure 1H ). Together, these results suggest that O-GlcNAc is important for both maintaining and inducing pluripotency. We also demonstrate here that O-GlcNAcylation is critical for Oct4 transcriptional activity and that inhibition of Oct4 O-GlcNAcylation disrupts pluripotency. O-GlcNAcylation of Oct4 is important for Oct4 to activate many pluripotency-related genes such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1 (Figure 7) .
ESCs are commonly cultured in high-glucose (25 mM) media, and the restriction of nutrients such as glucose and amino acids is a basic strategy employed in the in vitro differentiation of ESCs (Mochizuki et al., 2011) . Because O-GlcNAc signaling is sensitive to nutrient status, we hypothesized that nutrient status may affect pluripotency and differentiation via O-GlcNAcylation. In accordance with this idea, we found that reprogramming is inefficient under low-glucose (5.5 mM) conditions compared to high-glucose conditions ( Figure 1J ).
The threonine 228 residue on Oct4 undergoes O-GlcNAcylation, and T228-O-GlcNAc increased Oct4 activity (Figures 3, 4 , and 5). We could not detect O-GlcNAc at Oct4 serine 229 via mass spectroscopy, although Oct4 S229A was reduced in O-GlcNAc level ( Figure 3C ). This does not completely eliminate the possibility that S229 is also O-GlcNAcylated, but the effect of S229A is much milder than that of T228A (Figures 4 and 5) . The double alanine mutant of Oct4 at T228 and S229 was not completely depleted in O-GlcNAcylation (Figure 3C ), leaving the possibility that additional O-GlcNAcylation site(s) may exist. However, we demonstrate that T228 is the major O-GlcNAcylation site that regulates Oct4 transcriptional activity. In contrast to Oct4 WT, Oct4 T228A transcriptional activity was not affected by perturbation of O-GlcNAc levels ( Figure 5C ).
Serine 229 on Oct4 has been identified as a phosphorylation site (Swaney et al., 2009 ) and has been predicted to be modified/ catalyzed by PKA (protein kinase A) through bioinformatic analyses (Saxe et al., 2009) . Oct4 S229D, which mimics phosphorylation, decreased Oct4 reporter activity. However, contradictory results have been obtained by the same researchers with treatment of a PKA activator, 8-Br-cAMP, which elevated both Oct4 protein levels and reporter activity (Saxe et al., 2009) . ESCs treated with 8-Br-cAMP showed conflicting results with ESC differentiation occurring in the presence of LIF, and ESC self renewal maintained in the absence of LIF (Faherty et al., 2007) . Our results show that Oct4 S229D completely loses transcriptional activity ( Figures 5A and 5D ) and cannot induce reprogramming to iPSCs (Figures 4A and 4B) . Considering that Oct4 S229A retains $50% of WT transcriptional activity (Figure 5A ) and $30% of WT ability to induce iPSCs ( Figure 4A ), Oct4 S229D may faithfully mimic phosphorylation. Although it is clear that phosphorylation at S229 negatively regulates Oct4 activity, the kinase(s) responsible for the modification is (are) not apparent yet.
Using microarray, we identified potential target genes that are dominantly regulated by O-GlcNAcylated Oct4. To select direct target genes, we used serial ChIP assay to purify Oct4 and then the O-GlcNAcylated protein-bound DNA. Several pluripotencyrelated factors, such as Klf2, Klf5, Nr5a2, Tbx3, and Tcl1, are identified as direct targets. Among them, Klf2 and Klf5 can reprogram MEFs in conjunction with Oct4 and Sox2 (Nakagawa et al., 2008) and sustain ESC self-renewal (Hall et al., 2009 ). Nr5a2 can replace Oct4 (Heng et al., 2010) in the reprogramming process and Tbx3 improves the germline competency of iPSCs . By regulating the expression levels of these genes, O-GlcNAc of Oct4 may adjust the pluripotent state according to the external signals.
Polycomb group (PcG) complexes have been suggested to link O-GlcNAc cycling to epigenetic regulation of chromatin and ESC differentiation . PcG complexes set the stage in ESCs for the acquisition and maintenance of specific developmental gene expression programs during development. PcG complexes are essential for establishment of bivalent chromatin, which carry both active and repressive histone marks and are a characteristic of ESCs (Sauvageau and Sauvageau, 2010; Surface et al., 2010) . OGT is a component of PcG complexes, and its activity is essential for full repression by PcG (Gambetta et al., 2009 ). Thus, OGT may regulate ESC differentiation in part through PcG complexes. However, PcG complexes are not required for the maintenance of self-renewal in ESCs (Sauvageau and Sauvageau, 2010; Surface et al., 2010) and cannot sufficiently account for the critical role of O-GlcNAc in ESC self-renewal.
In this study, we reveal that O-GlcNAc regulates the function of Oct4 and Sox2, which are core components of the pluripotency network. In undifferentiated ESCs, Oct4 is O-GlcNAcylated and upregulates several genes critical for maintenance of ESC identity. Upon differentiation, O-GlcNAc is rapidly detached from Oct4 and the expression of pluripotency-related Oct4 target genes is decreased. These findings may explain why O-GlcNAc is critical for pluripotency.
EXPERIMENTAL PROCEDURES
Mice C57BL/6 and pOct4-GFP mice (Jackson Laboratory) used for mouse embryonic fibroblasts (MEFs) preparation were maintained as described (Cho et al., 2010) . Animal experimental procedures were approved by Institutional Animal Care and Use Committee (IACUC) of Seoul National University, Korea (SNU-070419-4).
Cell Culture E14 mouse ESCs were cultured as described (Jang et al., 2009 ). ZHBTc4 cells (Niwa et al., 2000) and ZHBTc4 F-Oct4 cells (van den Berg et al., 2010) were Doxycycline-Dependent Expression of shRNAs Dox-dependent expression of shRNAs was done with Knockout Tet RNAi System H (Clontech Laboratories, Inc.).
Self-Renewal Assay
Self-renewal assay (colony-forming assay) was done as described (Chambers et al., 2007) .
Reprogramming
Reprogramming was principally done per the Lim group . 
ACCESSION NUMBERS
The microarray data are available in the Gene Expression Omnibus (GEO) database (http://www.ncbi.nlm.nih.gov/gds) under the accession number GSE36322 and the ChIP-seq data have the accession number GSE36388.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures, six figures, and five tables and can be found with this article online at doi:10.1016/j.stem.2012.03.001.
